Valuation
- Market cap
- 114,234,000
- Revenue TTM
- $0
- Net income TTM
- $-57,590,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 251,800
- Avg volume
- 124,436
- Day's range
- $4.66 – $5.45
- Shares out
- 21,884,000
- Stochastic %K
- 37%
- Beta
- 3.80
- Analysts
- Sell
- Price target
- $11.11
Company profile
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 858 225 7696
- Website
- https://aardvarktherapeutics.com
- Address
- 4370 La Jolla Village Drive, Suite 1050, San Diego, United States
Latest news
No headlines yet.
